A reaction limited in vivo dissolution model for the study of drug absorption: Towards a new paradigm for the biopharmaceutic classification of drugs

No abstract is available for this paper.

• Publication year

  2018

• Venue

  European Journal of Pharmaceutical Sciences

• Publication date

  2018-05-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejps.2018.02.003PMID 29425862
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral bioavailability enhancement through supersaturation: an update and meta-analysis

  2017cited by this paper
• Evolution of Choice of Solubility and Dissolution Media After Two Decades of Biopharmaceutical Classification System

  2017cited by this paper
• Development of a Unified Dissolution and Precipitation Model and Its Use for the Prediction of Oral Drug Absorption.

  2016cited by this paper
• Theoretical Analysis of Drug Dissolution: I. Solubility and Intrinsic Dissolution Rate.

  2016cited by this paper
• Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying

  2016cited by this paper
• The Precipitation Behavior of Poorly Water-Soluble Drugs with an Emphasis on the Digestion of Lipid Based Formulations

  2015cited by this paper
• In vitro–in vivo correlations: general concepts, methodologies and regulatory applications

  2015cited by this paper
• Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug

  2015cited by this paper
• Scientific considerations concerning the EMA change in the definition of "dose" of the BCS-based biowaiver guideline and implications for bioequivalence.

  2015cited by this paper
• Biorelevant dissolution of poorly soluble weak acids studied by UV imaging reveals ranges of fractal-like kinetics.

  2014cited by this paper
• A non-binary biopharmaceutical classification of drugs: the ABΓ system.

  2014cited by this paper
• Fast-Dissolving Core-Shell Composite Microparticles of Quercetin Fabricated Using a Coaxial Electrospray Process

  2014cited by this paper
• Amorphization strategy affects the stability and supersaturation profile of amorphous drug nanoparticles.

  2014cited by this paper
• Is the full potential of the biopharmaceutics classification system reached?

  2014cited by this paper
• The impact of the EMA change in definition of "dose" on the BCS dose-solubility ratio: a review of the biowaiver monographs.

  2014cited by this paper
• Electrospinning of diosmin from aqueous solutions for improved dissolution and oral absorption.

  2014cited by this paper
• Elucidating the Role of Dose in the Biopharmaceutics Classification of Drugs: The Concepts of Critical Dose, Effective In Vivo Solubility, and Dose-Dependent BCS

  2012cited by this paper
• In vitro–In Vivo Correlations: Tricks and Traps

  2012cited by this paper
• Solution-mediated phase transformation: significance during dissolution and implications for bioavailability.

  2012cited by this paper
• Comparison and analysis of theoretical models for diffusion-controlled dissolution.

  2012cited by this paper
• Supersaturated dissolution data and their interpretation: the TPGS–carbamazepine model case

  2011cited by this paper
• Biorelevant dissolution methods and their applications in in vitroin vivo correlations for oralformulations

  2010cited by this paper
• Power law IVIVC: an application of fractional kinetics for drug release and absorption.

  2010cited by this paper
• Biorelevant Dissolution Methods and Their Applications in In Vitro- In Vivo Correlations for Oral Formulations~!2009-09-14~!2009-11-02~!2010-04-29~!

  2010cited by this paper
• The Use of Biorelevant Dissolution Media to Forecast the In Vivo Performance of a Drug

  2010cited by this paper
• Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?

  2009cited by this paper
• Fractional kinetics in drug absorption and disposition processes

  2009cited by this paper
• Development of a reaction-limited model of dissolution: application to official dissolution tests experiments.

  2008cited by this paper
• Using measured pKa, LogP and solubility to investigate supersaturation and predict BCS class.

  2008cited by this paper
• Turbidimetric measurement and prediction of dissolution rates of poorly soluble drug nanocrystals.

  2007cited by this paper
• Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.

  2006cited by this paper
• A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system.

  2006cited by this paper
• Identification of Biowaivers Among Class II Drugs: Theoretical Justification and Practical Examples

  2004cited by this paper
• Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System

  2004cited by this paper
• The “High Solubility” Definition of the Current FDA Guidance on Biopharmaceutical Classification System May Be Too Strict for Acidic Drugs

  2004cited by this paper
• The Mean Dissolution Time Depends on the Dose/Solubility Ratio

  2003cited by this paper
• Quantitative Biopharmaceutics Classification System: The Central Role of Dose/Solubility Ratio

  2003cited by this paper
• On the Heterogeneity of Drug Dissolution and Release

  2000cited by this paper
• Solubilization and Interaction of Sulindac with β-Cyclodextrin in the Solid State and in Aqueous Solution

  1998cited by this paper
• Solubilization and interaction of sulindac with beta-cyclodextrin in the solid state and in aqueous solution.

  1998cited by this paper
• Gastrointestinal Drug Absorption: Is It Time to Consider Heterogeneity as Well as Homogeneity?

  1997cited by this paper
• Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption.

  1996cited by this paper
• A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

  1995cited by this paper
• Determination of fractal reaction dimension in dissolution studies

  1995cited by this paper
• Estimating the Fraction Dose Absorbed from Suspensions of Poorly Soluble Compounds in Humans: A Mathematical Model

  1993cited by this paper
• Fractal Reaction Kinetics

  1988cited by this paper
• Drug dissolution studies in milk using the automated flow injection serial dynamic dialysis technique

  1986cited by this paper
• Dissolution of struvite urinary stones. Experimental studies in vitro.

  1976cited by this paper
• Metastable supersaturation. Physicochemical studies provide new insights into formation of renal and biliary tract stones.

  1974cited by this paper
• Diffusional Models Useful in Biopharmaceutics: Drug Release Rate Processes

  1967cited by this paper
• Effect of solubilisation on the antibacterial activity of hexachlorophane

  1966cited by this paper

• Coupling Drug Dissolution with BCS

  2024cites this paper
• Effect of Food Viscosity on Drug Dissolution

  2023cites this paper
• Re-writing Oral Pharmacokinetics Using Physiologically Based Finite Time Pharmacokinetic (PBFTPK) Models

  2022cites this paper
• Application of UV dissolution imaging to pharmaceutical systems.

  2021cites this paper
• The Novel Use of PVP K30 as Templating Agent in Production of Porous Lactose

  2021cites this paper
• Square root law model for the delivery and intestinal absorption of drugs: a case of hydrophilic captopril

  2021cites this paper
• Quantitative Assessment of the in Vivo Dissolution Rate to Establish a Modified IVIVC for Isosorbide Mononitrate Tablets.

  2021cites this paper
• Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Support Waivers of In Vivo Clinical Studies: Current Status, Challenges, and Opportunities.

  2020cites this paper
• Revising Pharmacokinetics of Oral Drug Absorption: I Models Based on Biopharmaceutical/Physiological and Finite Absorption Time Concepts

  2020cites this paper
• Correction to: Revising Pharmacokinetics of Oral Drug Absorption: I Models Based on Biopharmaceutical/Physiological and Finite Absorption Time Concepts

  2020cites this paper
• The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines.

  2019cites this paper
• Panos Macheras: a pioneering scientist in pharmaceutical science

  2019cites this paper
• On the unphysical hypotheses in pharmacokinetics and oral drug absorption: Time to utilize instantaneous rate coefficients instead of rate constants

  2019cites this paper